{"id":163614,"date":"2025-11-05T04:37:07","date_gmt":"2025-11-05T04:37:07","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/163614\/"},"modified":"2025-11-05T04:37:07","modified_gmt":"2025-11-05T04:37:07","slug":"trump-negotiating-deal-with-ozempic-maker-to-sell-some-weight-loss-drugs-for-149","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/163614\/","title":{"rendered":"Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149"},"content":{"rendered":"

The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly<\/a> LLY 1.15%increase; green up pointing triangle<\/a> and Novo Nordisk<\/a> NOVO.B -0.03%decrease; red down pointing triangle<\/a> that would allow the lowest doses of some of their obesity drugs<\/a> to be sold to consumers at $149 for a month\u2019s supply via TrumpRx, according to people familiar with the matter.<\/p>\n

The deals would also result in Medicare and Medicaid covering the drugs for weight loss, the people said, which would be a boon to the companies.<\/p>\n

Copyright \u00a92025 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly LLY 1.15%increase; green up pointing triangle…\n","protected":false},"author":2,"featured_media":163615,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[274],"tags":[7944,94544,82639,8915,18,1465,18131,518,18997,3334,94541,135,88945,474,82483,19,3912,40506,17,3544,3521,94550,94545,94546,94547,94548,94551,94549,6403,82656,94542,3865,37634,462,69291,88944,1539,6526,94543,508,7176,2900,7840,87959,9436,44285,790,82638,20912,2990,82655,26243,384,642,41580],"class_list":{"0":"post-163614","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-community","9":"tag-dknovo-b","10":"tag-domestic-politics","11":"tag-drink","12":"tag-eire","13":"tag-eli-lilly","14":"tag-financial-services","15":"tag-food","16":"tag-food-drink","17":"tag-general-news","18":"tag-government-sponsored-health-insurance","19":"tag-health","20":"tag-health-medical-insurance","21":"tag-healthcare","22":"tag-healthcare-life-sciences","23":"tag-ie","24":"tag-insurance","25":"tag-international-relations","26":"tag-ireland","27":"tag-life-sciences","28":"tag-lifestyle","29":"tag-linki1-wp-wsj-0003080739","30":"tag-linki2-wp-wsj-0003080739","31":"tag-linki3-wp-wsj-0003080739","32":"tag-linki4-wp-wsj-0003080739","33":"tag-linki5-wp-wsj-0003080739","34":"tag-linki7-wp-wsj-0003080739","35":"tag-linki8-wp-wsj-0003080739","36":"tag-living","37":"tag-living-lifestyle","38":"tag-lly","39":"tag-medical-conditions","40":"tag-medical-insurance","41":"tag-medication","42":"tag-mental-fitness","43":"tag-non-life-insurance","44":"tag-north-america","45":"tag-novo-nordisk","46":"tag-novo-b-ko","47":"tag-nutrition","48":"tag-obesity","49":"tag-pharmaceuticals","50":"tag-physical","51":"tag-physical-mental-fitness","52":"tag-political","53":"tag-political-general-news","54":"tag-politics","55":"tag-politics-international-relations","56":"tag-social-issues","57":"tag-society","58":"tag-society-community","59":"tag-synd","60":"tag-united-states","61":"tag-weight-management","62":"tag-wsj-pro-wsj-com"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/163614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=163614"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/163614\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/163615"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=163614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=163614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=163614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}